Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1523, 2006-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dasatinib a START-R in imatinib-resistant CML
Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. :
Access to resources
Recommend
Dasatinib: a once-daily option for imatinib-resistant CML
Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. :
Dasatinib deals to imatinib-resistant disease
Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. :
Dasatinib tops imatinib for CML on economic level
Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. :
Dasatinib tops imatinib for CML on economic level
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. :